Clinical Cancer Investigation Journal

: 2021  |  Volume : 10  |  Issue : 3  |  Page : 97--101

Coronavirus and disease such as cancer

Zahra Tolou-Ghamari 
 Deputy of Research and Technology, Metabolic Liver Disease Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Correspondence Address:
Zahra Tolou-Ghamari
Deputy of Research and Technology, Metabolic Liver Disease Research Center, Isfahan University of Medical Sciences, Isfahan

A recently published article confirmed that more than 50.0% of infected patients with cancer are susceptible to develop severe form of coronavirus disease 2019 (COVID-19). Currently, acute and chronic diseases caused by COVID-19 in humans are spreading quickly worldwide. Therefore, this study aimed to provide a better understanding of the COVID-19 and disease such as cancer. Based on our previous studies and experiences in the field of cancers' prevalence and incidence, we searched, selected, and studied articles in PubMed (National Library of Medicine), Scopus, and Web of Science with the keywords relevant to “Coronavirus,” “Disease,” and “Cancer.” In the initiation of cancer, viral infection plays a key role in signaling factor activation. Due to immunocompromised state, there is a higher risk of severe illness such as severe acute respiratory symptoms from COVID-19 in those with cancer. Patients with lymphoblastic leukemia or those who need to undergo chemotherapy are at higher risk for COVID-19 infection. Mild flu-like symptoms, fever, cough, fatigue, sputum production and shortness of breath, respiratory failure, arrhythmias, brain stroke, acute cardiac injury, shock, multiple organ failure, and death are some of the reported signs of infection to COVID-19 in patients with cancer. Published articles, emphasis for more attention during COVID-19 pandemic situation in patients with different types of cancers such as; Skin, stomach, colon, bladder, and lung cancer. Forecasts a time of change for a new type of coronavirus that might be associated with a silent period of at least 3–7 years in the near future. Finally, as patients with cancer are more susceptible to develop severe clinical consequences, therefore, health authorities should have advanced pharmacotherapy plans to alleviate the adverse effects of the COVID-19 on cancer patients.

How to cite this article:
Tolou-Ghamari Z. Coronavirus and disease such as cancer.Clin Cancer Investig J 2021;10:97-101

How to cite this URL:
Tolou-Ghamari Z. Coronavirus and disease such as cancer. Clin Cancer Investig J [serial online] 2021 [cited 2021 Sep 21 ];10:97-101
Available from:;year=2021;volume=10;issue=3;spage=97;epage=101;aulast=Tolou-Ghamari;type=0